Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234 | 0 | 0 | N/A | 0 |
| Receivables | 554 | 0 | 0 | N/A | 0 |
| TOTAL | $1,423 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 740 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,398 | 0 | 0 | 0 | 0 |
| TOTAL | $2,138 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,560 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,414 | 0 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 1,164 | 0 | 0 | 0 | 0 |
| Other current liabilities | 1,000 | 0 | 0 | N/A | 0 |
| TOTAL | $5,802 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,222 | 0 | 0 | 0 | 0 |
| TOTAL | $1,359 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,162 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,252 | N/A | N/A | N/A | N/A |
| Retained earnings | -10,110 | 0 | 0 | N/A | 0 |
| TOTAL | $-3,601 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $3,560 | $0 | $0 | $0 | $0 |